Shotlee LogoShotlee
Blog
Download on theApp Store
Become aBeta Tester
Skip to main content
DrMedHealth.com Introduces National Telehealth Access for GLP-1 Medical Wellness Programs - Featured image
Health

DrMedHealth.com Introduces National Telehealth Access for GLP-1 Medical Wellness Programs

DrMedHealth.com is now offering its GLP-1 medical weight loss programs across the nation, giving adults in the United States and Washington, DC, access to licensed doctors and prescription-based weight management services. The platform facilitates a comprehensive telehealth experience, enabling patients to undergo online health evaluations, receive assessments from licensed healthcare professionals, and, if deemed appropriate, commence treatment remotely.

Shotlee·December 26, 2025·Updated Jan 27, 2026·3 min read
Share:

Contents

  1. 01DrMedHealth.com Launches National Telehealth Access for GLP-1 Medical Wellness Programs
  2. 02Program Features and Benefits
  3. 03Key Patient Advantages:

DrMedHealth.com Launches National Telehealth Access for GLP-1 Medical Wellness Programs

DrMedHealth.com, a LegitScript-certified telehealth platform run by Public Health Solution LLC, has announced the nationwide availability of its GLP-1 medical weight loss programs, broadening access to licensed physicians and prescription-based weight management services for adults across the United States and Washington, DC.

This expansion occurs amidst increasing demand for GLP-1 therapies within medically supervised weight management contexts. DrMedHealth.com offers a fully compliant telehealth experience, enabling patients to complete a complimentary online health assessment, undergo evaluation by a licensed healthcare provider, and—when clinically suitable—initiate treatment without requiring in-person appointments. Health tracking apps like Shotlee can help monitor progress and adherence to treatment plans.

The majority of patients receive a response from a provider within 2 to 24 hours. Moreover, medications are shipped discreetly to their homes in as little as 2 to 4 days.

Through its nationwide network of providers, DrMedHealth.com provides access to FDA-approved GLP-1 medications, which include Wegovy Registered, Ozempic Registered, and Mounjaro Registered, alongside compounded alternatives such as semaglutide and tirzepatide. These are prepared by licensed U.S. compounding pharmacies. Treatment options are available in both injectable and oral forms, allowing providers to customize treatment strategies according to each patient’s medical background, preferences, and specific clinical requirements.

Program Features and Benefits

Programs begin at a monthly cost of $249, which encompasses:

Track your medication journey

Join thousands using Shotlee to track GLP-1 medications.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Become aBeta Tester
  • Licensed provider assessment and continuous monitoring
  • Prescription management
  • Medication delivery and shipping

Notably, insurance coverage is not mandatory, and payments via HSA/FSA are accepted.

According to a spokesperson for DrMedHealth.com, their aim is to enhance the accessibility of medically guided weight management while upholding standards of safety and transparency. By integrating licensed physicians, secure telehealth technology, and patient education, they empower individuals to take significant steps towards improved health, commencing with a free assessment.

DrMedHealth.com adheres to stringent HIPAA-compliant data protection protocols, holds LegitScript certification, and collaborates exclusively with licensed healthcare providers and pharmacies based in the U.S. The platform prioritizes patient education and clear disclosures, offering transparency regarding FDA-approved medications versus compounded formulations, which, while not FDA-approved, are prescribed at the provider’s discretion.

Serving thousands of patients across the nation, DrMedHealth.com boasts a patient satisfaction rating of 4.9 stars. It continues to establish itself as a reliable telehealth platform for individuals seeking clinically supervised weight loss solutions, free from the logistical obstacles associated with conventional clinics.

Key Patient Advantages:

  • 24/7 access to free online health evaluations
  • Access to licensed physicians throughout all 50 states and Washington, DC
  • Expedited provider reviews and home delivery services
  • Discreet packaging coupled with ongoing patient support

Original source: openPR.com - Open Public Relations Free of Charge

View original article →
#telehealth#GLP-1#weight loss#medical weight management#DrMedHealth.com
  1. Home
  2. Blog
  3. DrMedHealth.com Introduces National Telehealth Access for GLP-1 Medical Wellness Programs

Related Articles

Millennial Stars Admit to Ozempic & GLP-1 Use: Transformations
GLP-1 Medications

Millennial Stars Admit to Ozempic & GLP-1 Use: Transformations

Midlife weight gain is hitting millennial stars hard, but many are turning to Ozempic and other GLP-1s for help. Celebrities including Amy Schumer, Golnesa 'GG' Gharachedaghi, and Serena Williams have openly admitted to using these medications, sharing their triumphs, side effects, and transformations. Discover their stories and the science behind these popular drugs.

SNAC in Ozempic and Wegovy Tablets Raises Gut Health Questions, Study Finds
GLP-1 Medications

SNAC in Ozempic and Wegovy Tablets Raises Gut Health Questions, Study Finds

New research uncovers potential effects of SNAC—the hidden ingredient enabling Ozempic and Wegovy tablets—on gut health. In a 21-day animal study, repeated exposure led to shifts in harmful gut bacteria, elevated inflammation, and depleted cognitive proteins. While not proving harm in humans, findings urge caution as oral semaglutide use surges.

73M Overweight Urban Indians, GLP-1 Awareness <5%: Kantar Report
Metabolic Health

73M Overweight Urban Indians, GLP-1 Awareness <5%: Kantar Report

Urban India faces a metabolic crisis with 73 million overweight adults, yet GLP-1 therapy awareness hovers below 5%, per Kantar's latest report. Despite high weight loss intent, a stark knowledge gap limits adoption of these diabetes and obesity treatments. Explore the data, demographics, and paths forward for better metabolic health.

Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Get Started

Resources

  • Health Blog
  • Support Center
  • System Status

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with ♥ for the community